文献速递乳房整形与再造美容整形

经腹隆乳术:14年114例病例回顾

Transabdominal Breast Augmentation: A Review of 114 Cases Performed over 14 Years.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

一项14年单术者回顾性研究,评估经腹壁整形切口置入乳房假体联合腹壁整形术的安全性与效果。114例患者平均随访19.2个月,多数在监护麻醉加肋间神经阻滞下完成,主要并发症发生率为7.0%。结论认为该联合术式在合适选择的健康患者中安全可靠,适用于轻至中度乳房下垂且要求同期腹壁整形与双侧隆乳者。

要点

  • 经腹隆乳术适用于轻度乳房下垂且要求同期腹壁整形与隆乳的合适患者。
  • 多数手术在监护麻醉加肋间神经阻滞下完成(93.9%),仅少数需全麻(6.1%)。
  • 主要并发症发生率为7.0%,包括假体移位需修整和Baker III级包膜挛缩。

核心结论

  • 经腹隆乳术在合适选择的健康患者中安全可靠,可用于轻至中度乳房下垂且要求同期隆乳与腹壁整形者。

研究设计与样本

  • 14年单术者回顾性研究,纳入114例经下腹横切口腹壁整形同期行双侧乳房假体置入的患者。

主要发现

  • 114例患者平均随访19.2个月,107例(93.9%)在监护麻醉加肋间神经阻滞下完成,7例(6.1%)全麻。
  • 多数并发症沿腹壁整形皮瓣中央远端可预测地发生且为轻微(小范围伤口裂开、血清肿、轻度皮肤感染)。
  • 主要并发症8例(7.0%),包括2例假体移位需修整和1例Baker III级包膜挛缩(该患者为每日半包吸烟者,BMI 27 kg/m²)。

关键数值与推荐

  • 入选条件包括轻度下垂、术前至少4周戒烟并此后持续戒烟、无上腹部手术史或显著乳房手术史。

临床怎么用

  • 对要求同期腹壁整形与隆乳的合适患者,可经腹壁整形切口置入乳房假体,优先在监护麻醉加肋间神经阻滞下完成。

局限性

  • 单术者回顾性研究,证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abdominoplasty patients are frequently candidates for breast rejuvenation as well. Transabdominal breast augmentation permits insertion of breast implants through the abdominoplasty incision. This combined procedure is preferentially performed in an outpatient setting under monitored anesthesia care and nerve blocks. METHODS: This study was a 14-year retrospective review of a single surgeon's technique and outcomes using transabdominal breast augmentation through a low transverse abdominoplasty incision in select patients requesting simultaneous abdominoplasty and bilateral breast augmentation. Patients had minimal ptosis, smoking cessation a minimum of 4 weeks before surgery and indefinitely thereafter, and a lack of superior abdominal or significant breast surgery. RESULTS: The study's 114 patients had a mean follow-up of 19.2 months. The procedure was performed under monitored anesthesia care with intercostal nerve blocks for most patients [n = 107 (93.9 percent)] and general anesthesia [n = 7 (6.1 percent)] for a few. Seventy-nine patients [n = 74 (64.9 percent)] underwent additional procedures, with most (n = 48) undergoing suction-assisted lipectomy. Many patients underwent multiple procedures. Most complications occurred predictably along the central distal abdominoplasty flap and were minor (small wound breakdown, seroma, and mild skin infection). Major complications [n = 8 (7.0 percent)] included two patients with implant malposition requiring revision and one patient with a Baker grade III capsule; notably, this patient was a half-pack-per-day smoker with a body mass index of 27 kg/m. CONCLUSIONS: Transabdominal breast augmentation is a safe, reliable procedure in the appropriately selected, healthy patient and may be used in minimally to moderately ptotic patients who request concurrent breast augmentation and abdominoplasty. Morbidity compares favorably to reported abdominoplasty series in the appropriately selected patient. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Bhatt RA, Iyengar RJ, Karacaoglu E, et al. Transabdominal Breast Augmentation: A Review of 114 Cases Performed over 14 Years. Plast Reconstr Surg. 2017. PMID: 28841606. doi:10.1097/PRS.0000000000003611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。